SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $22.20 thousand as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-09-24
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22.20K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $27.43K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33.15K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $39.33K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $22.20K 10-Q · filed 2026-09-24 |
| 2026-03-31 | $27.43K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $33.15K 10-K · filed 2026-03-31 |
| 2025-09-30 | $39.33K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $45.97K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $53.05K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $60.55K 10-K · filed 2025-02-26 |
| 2024-09-30 | $68.44K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $76.74K 10-Q · filed 2024-09-04 |
| 2024-03-31 | $85.41K 10-Q/A · filed 2024-09-04 |
| 2023-12-31 | $94.44K 10-K/A · filed 2024-09-04 |
| 2023-03-31 | $727.00 10-Q · filed 2023-05-25 |
| 2022-12-31 | $1.98K 10-K · filed 2023-03-15 |
| 2022-09-30 | $3.86K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |